Aspro Frederic Michel

Frederic Michel is a cardiovascular researcher whose work centers on vascular biology, inflammation, and cardiac remodeling. His scholarship bridges experimental and translational cardiology, with sustained focus on how systemic inflammation, hypertension, and autoimmune disease influence endothelial function and left ventricular performance. He has also contributed to clinical guidance, including consensus work on structural heart interventions.

His publications highlight the mechanistic role of inflammatory mediators, microRNAs, and adhesion molecules in endothelial dysfunction and myocardial impairment. Using well-established animal models of hypertension and collagen-induced arthritis, his studies elucidate links between TNF-α signaling, miR-146a-5p and miR-155-5p expression, vascular stiffness, and diastolic dysfunction. This integrative approach connects molecular pathways to vascular reactivity, arterial wave reflection, and cardiac deformation.

Recent work extends to sex differences, estrogen deficiency, pentraxin-3, and nutraceutical interventions such as quercetin, underscoring expertise in both pathophysiology and therapeutic modulation. Collectively, his research advances understanding of inflammation-driven cardiovascular remodeling and identifies biomarkers and targets relevant to hypertensive and rheumatologic heart disease.